Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

First postgraduate degree in Forensic Genetics in Africa
2010-03-19

 
At the launch were, from the left, front: Ms Christa Swanepoel (Applied Biosystems), Ms Karen Ehlers (Department of Genetics, UFS), Dr Carolyn Hancock and Ms Vanessa Lynch (both from DNA Project). Middle row: Dr. Sphie Mukwana (Director: Biotech Forensics, Kenya), Mr Pierre Joubert (Director: SAPS Forensic Science Laboratory) and Prof. Johan Spies (Chairperson: Department of Genetics, UFS). Back row: Mr Izak van Niekerk (Southern Cross Biotechnologies) and Mr Loen Ehlers (National Prosecution Authority).
Photo: Stephen Collett


The Department of Genetics at the University of the Free State (UFS) recently launched the first postgraduate degree offered by a tertiary institution in Forensic Genetics in Africa.

“We are at the beginning of something special. The UFS has developed the programme with the aim of providing graduates with the skills and knowledge they would require to work in the field of forensic biology. These graduates will be the first group of professionals that have undergone tertiary training in order to assist in the resolution of crime through forensic science in South Africa. It has also put the UFS in the forefront of training of this nature,” said Prof. Johan Spies, the departmental chairperson.

According to Mr Pierre Joubert, Director at the Forensic Science Laboratory (FSL) in Pretoria, students trained in this programme would easily be employed by the FSL since they would have the appropriate applied and technical training in forensic science.

Currently the FSL has no personnel with degrees in forensic science in its employ. It employs B.Sc. graduates in the fields of microbiology, genetics, molecular biology and biochemistry as forensic analysts. These employees then go through an extensive supplementary training programme for about six months.

Dr Sophie Mukwana, Director of Biotech Forensics in Kenya, said the launch of this programme in South Africa would benefit African countries like Kenya which relied on the USA for this kind of training. She said they hoped to partner with the UFS in this venture.

Applied Biosystems and Southern Cross Biotechnology have donated the necessary equipment to the UFS for this training.

“It is not only important that students should see the equipment but they should also know how to operate it,” said Ms Vanessa Lynch, from the DNA Project.

The DNA Project, in conjunction with the FSL and the UFS, has developed the learning materials which will be presented at the UFS from 2011.

Media Release
Issued by: Mangaliso Radebe
Assistant Director: Media Liaison
Tel: 051 401 2828
Cell: 078 460 3320
E-mail: radebemt@ufs.ac.za  

19 March 2010
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept